IL130304A0 - Leukotriene antagonists for oral squamous cell carcinoma - Google Patents

Leukotriene antagonists for oral squamous cell carcinoma

Info

Publication number
IL130304A0
IL130304A0 IL13030497A IL13030497A IL130304A0 IL 130304 A0 IL130304 A0 IL 130304A0 IL 13030497 A IL13030497 A IL 13030497A IL 13030497 A IL13030497 A IL 13030497A IL 130304 A0 IL130304 A0 IL 130304A0
Authority
IL
Israel
Prior art keywords
cell carcinoma
squamous cell
oral squamous
leukotriene antagonists
leukotriene
Prior art date
Application number
IL13030497A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL130304A0 publication Critical patent/IL130304A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13030497A 1996-12-13 1997-12-02 Leukotriene antagonists for oral squamous cell carcinoma IL130304A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3426996P 1996-12-13 1996-12-13
US4087497P 1997-03-21 1997-03-21
PCT/US1997/021953 WO1998025615A1 (en) 1996-12-13 1997-12-02 Leukotriene antagonists for oral squamous cell carcinoma

Publications (1)

Publication Number Publication Date
IL130304A0 true IL130304A0 (en) 2000-06-01

Family

ID=26710754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13030497A IL130304A0 (en) 1996-12-13 1997-12-02 Leukotriene antagonists for oral squamous cell carcinoma

Country Status (14)

Country Link
EP (1) EP0964683A4 (de)
JP (1) JP2001509142A (de)
KR (1) KR20000069452A (de)
CN (1) CN1245429A (de)
AU (1) AU726215B2 (de)
CA (1) CA2274855A1 (de)
EA (1) EA002742B1 (de)
IL (1) IL130304A0 (de)
NO (1) NO992846L (de)
NZ (1) NZ335922A (de)
PL (1) PL334241A1 (de)
TR (1) TR199901307T2 (de)
UA (1) UA47505C2 (de)
WO (1) WO1998025615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
KR101898879B1 (ko) 2014-03-05 2018-09-14 재단법인 진안홍삼연구소 홍삼 가공 추출물을 유효성분으로 함유하는 구강편평세포암의 예방, 개선 또는 치료를 위한 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372648A (ja) * 1986-09-16 1988-04-02 Sumitomo Pharmaceut Co Ltd 新規不飽和脂肪酸誘導体
ZA929051B (en) * 1991-11-25 1994-05-23 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists

Also Published As

Publication number Publication date
AU726215B2 (en) 2000-11-02
CN1245429A (zh) 2000-02-23
AU7845198A (en) 1998-07-03
UA47505C2 (uk) 2002-07-15
JP2001509142A (ja) 2001-07-10
NZ335922A (en) 2000-12-22
EP0964683A4 (de) 2002-08-14
EA002742B1 (ru) 2002-08-29
TR199901307T2 (xx) 1999-08-23
EA199900543A1 (ru) 2000-02-28
KR20000069452A (ko) 2000-11-25
PL334241A1 (en) 2000-02-14
CA2274855A1 (en) 1998-06-18
NO992846D0 (no) 1999-06-11
WO1998025615A1 (en) 1998-06-18
EP0964683A1 (de) 1999-12-22
NO992846L (no) 1999-06-11

Similar Documents

Publication Publication Date Title
GB2321598B (en) Reamer
GB9613470D0 (en) Small solid oral dosage form
ZA977011B (en) Muscarinic antagonists.
GB9726612D0 (en) Rotary cutter
AU139365S (en) Spout
ZA97303B (en) Pyrido-fused thienyl- and furanyl-oxazolidinones
AU130479S (en) Rotary cutter
ZA977326B (en) Tetrahydroquinoline derivatives
AU6450298A (en) Leukotriene antagonists useful for treating squamous cell carcinoma
AU132545S (en) Reamer
HU9503191D0 (en) Adhesion-receptor antagonists
IL140062A0 (en) Tetrahydroquinoline derivatives as glycine antagonists
IL130304A0 (en) Leukotriene antagonists for oral squamous cell carcinoma
AU2652395A (en) Leukotriene b4 antagonists
AU6570798A (en) Leukotriene antagonists useful for treating gingivitis
GB2331268A9 (en) Rotary cutting device
ZA97672B (en) Tetrahydroisoquinoline derivatives.
GB9726548D0 (en) Rotary cutters
HU9801453D0 (en) Single-phase protective surtch
GB9618980D0 (en) Cutters
HU9603342D0 (en) Quinoline derivatives as leukotriene antagonists
GB9612230D0 (en) Contsructional materials
CA82483S (en) Spout
CA80704S (en) Spout
CA82574S (en) Spout